Jim Biggins is founder, president and CEO of Access Vascular, a privately held medical device company developing a platform of venous access devices using the company’s novel bulk hydrophilic biomaterial technology. After shadowing physicians in a Boston hospital and witnessing first-hand the delay in administering antibiotics to a severely ill patient due to infection risks from a catheter, Jim knew there had to be a better way. Leveraging his engineering expertise and experience with hydrogels, he applied those skills to found Access Vascular in 2015, with the goal of reinventing venous access. Jim has previously held engineering and new product development positions at Ocular Therapeutix, Boston Scientific and Medtronic, and has launched more than a dozen medical technology products from concept through commercialization. Jim earned an M.B.A from Babson College and a B.S. in Plastics Engineering from the University of Massachusetts Lowell.